|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%). |
| 公司地址
| Hulsterweg 82, Venlo, LI, NLD, 5912 PL |
| 電話號碼
| +31 773556600 |
| 傳真號碼
| +31 773556658 |
| 公司網頁
| https://www.qiagen.com |
| 員工數量
| 5700 |
| Mr. Thierry Bernard |
Managing Director and Chief Executive Officer |
美元 588.37K |
31/03/2025 |
| Mr. Roland Sackers |
Managing Director and Chief Financial Officer |
美元 978.50K |
31/03/2025 |
|
|
| Dr. Eva Pisa |
Member of the Supervisory Board |
31/03/2025 |
| Dr. Ross L. Levine |
Member of the Supervisory Board |
31/03/2025 |
| Mr. Toralf Haag PhD |
Member of the Supervisory Board |
31/03/2025 |
| Mr. Bert van Meurs |
Member of the Supervisory Board |
31/03/2025 |
| Mr. Stephen H. Rusckowski |
Member of the Supervisory Board |
31/03/2025 |
| Dr. Metin Colpan |
Member of the Supervisory Board |
31/03/2025 |
| Ms. Eva Maria van Pelt |
Member of the Supervisory Board |
31/03/2025 |
| Mr. Lawrence A. Rosen |
Chairman of the Supervisory Board |
31/03/2025 |
| Dr. Elaine R. Mardis, PhD |
Member of the Supervisory Board |
31/03/2025 |
| Ms. Elizabeth E. Tallett |
Member of the Supervisory Board |
31/03/2025 |
|
|
|
|
